Real Life Effectiveness in Patients With Not Optimally Controlled Asthma
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
In real life, the investigators will be using different strategies including SMART therapy or
other ICS/LABA (medium and high dose) therapy and measure the efficacy for asthma control.
Phase:
Phase 4
Details
Lead Sponsor:
Far Eastern Memorial Hospital
Treatments:
Budesonide, Formoterol Fumarate Drug Combination Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination